BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30306412)

  • 1. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
    Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
    J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
    Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
    AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.
    Gregory J; Paisant A; Paulatto L; Raynaud L; Bertin C; Kerbaol A; Vullierme MP; Paradis V; Vilgrain V; Ronot M
    Eur J Radiol; 2020 Jul; 128():109027. PubMed ID: 32361381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound.
    Dong Y; Zhu Z; Wang WP; Mao F; Ji ZB
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):48-54. PubMed ID: 26818543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 7. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China.
    Wang H; Yang C; Rao S; Ji Y; Han J; Sheng R; Zeng M
    Eur J Radiol; 2018 Mar; 100():135-141. PubMed ID: 29496071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenoma: An unsolved diagnostic enigma.
    Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
    World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular adenoma: comparison between real-time contrast-enhanced ultrasound and dynamic computed tomography.
    Wang W; Liu JY; Yang Z; Wang YF; Shen SL; Yi FL; Huang Y; Xu EJ; Xie XY; Lu MD; Wang Z; Chen LD
    Springerplus; 2016; 5(1):951. PubMed ID: 27386395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
    Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
    Bröker MEE; Taimr P; de Vries M; Braun LMM; de Man RA; Ijzermans JNM; Dwarkasing RS
    AJR Am J Roentgenol; 2020 Jan; 214(1):81-89. PubMed ID: 31573852
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.
    Roche V; Pigneur F; Tselikas L; Roux M; Baranes L; Djabbari M; Costentin C; Calderaro J; Laurent A; Rahmouni A; Luciani A
    Eur Radiol; 2015 Jan; 25(1):186-95. PubMed ID: 25120205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
    AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
    [No Abstract]   [Full Text] [Related]  

  • 16. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
    Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
    Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent.
    Ricci P; Cantisani V; D'Onofrio M; Sahani D; Pagliara E; Calliada F; Mehmet E; Sanjeva K; Faccioli N; Pozzi-Mucelli R; D'Ambrosio U; Passariello R
    J Ultrasound Med; 2008 Dec; 27(12):1719-26. PubMed ID: 19022997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
    Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
    Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
    Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
    Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of hepatocellular adenoma during pregnancy: A prospective study.
    Gaspersz MP; Klompenhouwer AJ; Broker MEE; Thomeer MGJ; van Aalten SM; Steegers E; Terkivatan T; de Koning H; de Man RA; Ijzermans JNM
    J Hepatol; 2020 Jan; 72(1):119-124. PubMed ID: 31550458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.